Index RUT P/E - EPS (ttm) -4.37 Insider Own 10.76% Shs Outstand 59.43M Perf Week 6.47%
Market Cap 3.23B Forward P/E - EPS next Y -2.78 Insider Trans -3.42% Shs Float 54.56M Perf Month 16.42%
Income -260.72M PEG - EPS next Q -0.81 Inst Own 104.35% Short Float 17.67% Perf Quarter 26.18%
Sales 101.78M P/S 31.73 EPS this Y -38.97% Inst Trans 21.84% Short Ratio 19.63 Perf Half Y 30.00%
Book/sh 0.64 P/B 82.04 EPS next Y 37.40% ROA -75.00% Short Interest 9.64M Perf Year 119.85%
Cash/sh 5.22 P/C 10.12 EPS next 5Y -9.00% ROE -234.10% 52W Range 20.97 - 55.64 Perf YTD 14.92%
Dividend Est. - P/FCF - EPS past 5Y -6.04% ROI -89.54% 52W High -5.05% Beta 2.07
Dividend TTM - Quick Ratio 6.31 Sales past 5Y 175.40% Gross Margin 88.01% 52W Low 151.93% ATR (14) 2.27
Dividend Ex-Date - Current Ratio 6.53 EPS Y/Y TTM -32.68% Oper. Margin -260.93% RSI (14) 62.21 Volatility 4.30% 4.70%
Employees 226 Debt/Eq 6.42 Sales Y/Y TTM 132.57% Profit Margin -256.15% Recom 1.20 Target Price 59.30
Option/Short Yes / Yes LT Debt/Eq 6.40 EPS Q/Q 33.02% Payout - Rel Volume 0.57 Prev Close 54.55
Sales Surprise 1.00% EPS Surprise 22.42% Sales Q/Q 51.28% Earnings Aug 06 BMO Avg Volume 491.26K Price 52.83
SMA20 8.18% SMA50 9.91% SMA200 21.46% Trades
Volume 247,727 Change -3.15%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-18-24 Initiated H.C. Wainwright
Buy
$64
Sep-17-24 Initiated JMP Securities
Mkt Outperform
$64
May-08-24 Downgrade BofA Securities
Buy → Neutral
$49 → $42
Dec-19-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$29 → $55
Aug-01-23 Upgrade BofA Securities
Neutral → Buy
$22 → $27
Jan-18-23 Resumed Canaccord Genuity
Buy
$52
Aug-08-22 Upgrade Goldman
Neutral → Buy
$28
Aug-05-22 Upgrade BofA Securities
Underperform → Neutral
$8 → $20
Jun-17-22 Reiterated Needham
Buy
$40 → $25
Mar-02-22 Resumed Stifel
Buy
$23
Feb-17-22 Upgrade Ladenburg Thalmann
Neutral → Buy
$15
Dec-08-21 Initiated Wells Fargo
Overweight
$30
Nov-19-21 Downgrade Morgan Stanley
Overweight → Equal-Weight
$50 → $15
Sep-14-21 Resumed Goldman
Neutral
$14
Aug-04-21 Downgrade Ladenburg Thalmann
Buy → Neutral
Aug-04-21 Downgrade BofA Securities
Neutral → Underperform
$33 → $17
Nov-30-20 Downgrade BofA Securities
Buy → Neutral
$27 → $33
Jan-08-20 Initiated Goldman
Sell
$18
Jul-12-19 Upgrade Stifel
Hold → Buy
$34
Jul-08-19 Initiated Canaccord Genuity
Buy
$35
Show Previous Ratings
Sep-18-24 10:46AM
Sep-16-24 04:01PM
Sep-10-24 01:55PM
(Investor's Business Daily)
Sep-06-24 01:31PM
(Investor's Business Daily)
Aug-26-24 08:02AM
08:00AM
Loading…
08:00AM
Aug-13-24 04:01PM
Aug-06-24 08:15AM
07:00AM
Jul-31-24 09:10AM
Jul-23-24 08:00AM
07:30AM
Jul-11-24 04:01PM
(GlobeNewswire) +5.00%
+7.34%
Jul-08-24 08:00AM
Jun-28-24 08:00AM
04:01PM
Loading…
Jun-11-24 04:01PM
Jun-03-24 04:02PM
08:02AM
May-22-24 04:00AM
May-09-24 04:01PM
May-08-24 10:51AM
03:06AM
May-07-24 10:34PM
(Thomson Reuters StreetEvents) -10.32%
02:52PM
08:58AM
08:36AM
08:15AM
07:00AM
May-06-24 08:00AM
Apr-30-24 10:01AM
06:30PM
Loading…
Apr-29-24 06:30PM
Apr-28-24 09:20AM
Apr-24-24 04:01PM
Apr-16-24 04:01PM
Apr-01-24 08:00AM
Mar-25-24 08:00AM
Mar-22-24 07:01PM
Mar-20-24 01:49AM
01:49AM
01:49AM
Mar-11-24 04:01PM
Mar-06-24 04:01PM
Feb-23-24 12:04PM
Feb-22-24 10:19PM
(Thomson Reuters StreetEvents) -9.73%
08:10AM
07:35AM
07:01AM
07:00AM
Feb-16-24 03:00AM
Feb-15-24 10:00AM
Feb-14-24 02:30AM
Feb-13-24 03:04PM
Feb-08-24 04:01PM
Feb-07-24 08:00AM
Jan-31-24 08:00AM
Jan-12-24 04:01PM
Jan-04-24 07:00AM
06:58AM
Dec-30-23 11:01AM
Dec-15-23 04:01PM
(GlobeNewswire) +9.92%
-5.11%
Dec-13-23 07:00AM
Dec-08-23 05:05AM
Dec-06-23 07:00AM
Nov-17-23 09:03AM
Nov-13-23 04:01PM
Nov-07-23 08:25AM
08:00AM
07:00AM
Nov-02-23 08:00AM
Nov-01-23 10:01AM
Oct-31-23 10:01AM
Oct-25-23 08:00AM
Oct-19-23 08:45AM
Oct-17-23 04:01PM
Oct-13-23 04:01PM
Oct-12-23 09:55AM
Oct-10-23 08:00AM
Sep-22-23 08:00AM
Sep-19-23 08:01AM
Sep-08-23 05:01PM
04:01PM
07:59AM
Sep-06-23 07:59AM
Aug-28-23 08:00AM
Aug-07-23 08:00AM
Aug-04-23 04:01PM
Aug-03-23 06:07AM
Aug-01-23 08:35AM
07:00AM
Jul-19-23 08:00AM
Jul-18-23 08:00AM
Jul-17-23 06:00AM
Jul-14-23 04:40PM
Jul-13-23 04:01PM
Jun-29-23 12:45PM
Jun-17-23 02:01PM
Jun-07-23 08:00AM
Jun-06-23 04:01PM
Jun-05-23 08:46AM
May-22-23 08:00AM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. It is also involved in the clinical development program for setmelanotide in other rare MC4R pathway diseases, as well as a preclinical suite of investigational candidates for the treatment of congenital hyperinsulinism. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GOOD JENNIFER L Director Sep 17 '24 Option Exercise 21.54 31,751 684,066 34,751 Sep 19 04:30 PM GOOD JENNIFER L Director Sep 17 '24 Sale 52.40 31,751 1,663,803 3,000 Sep 19 04:30 PM JENNIFER GOOD Director Sep 17 '24 Proposed Sale 49.52 31,751 1,572,310 Sep 17 04:42 PM Cramer Pamela J. Chief Human Resources Officer Sep 09 '24 Option Exercise 19.02 4,099 77,963 17,599 Sep 11 04:32 PM Cramer Pamela J. Chief Human Resources Officer Sep 09 '24 Sale 50.03 4,099 205,062 13,500 Sep 11 04:32 PM TETRAULT LYNN A. Director Sep 10 '24 Option Exercise 10.51 17,501 183,944 20,501 Sep 11 04:31 PM TETRAULT LYNN A. Director Sep 09 '24 Option Exercise 18.99 3,199 60,749 6,199 Sep 11 04:31 PM TETRAULT LYNN A. Director Sep 10 '24 Sale 49.65 17,501 868,923 3,000 Sep 11 04:31 PM TETRAULT LYNN A. Director Sep 09 '24 Sale 50.04 3,199 160,068 3,000 Sep 11 04:31 PM GOOD JENNIFER L Director Sep 09 '24 Option Exercise 13.34 37,241 496,706 40,241 Sep 11 04:30 PM GOOD JENNIFER L Director Sep 09 '24 Sale 50.45 37,241 1,878,700 3,000 Sep 11 04:30 PM LYNN TETRAULT393 COMMONWEALTH Director Sep 10 '24 Proposed Sale 50.66 17,501 886,601 Sep 10 04:22 PM JENNIFER GOOD Director Sep 09 '24 Proposed Sale 49.25 16,749 824,888 Sep 09 04:31 PM Cramer Pamela J. Chief Human Resources Officer Aug 26 '24 Option Exercise 19.02 3,200 60,864 16,700 Aug 28 04:31 PM Cramer Pamela J. Chief Human Resources Officer Aug 26 '24 Sale 50.01 3,200 160,018 13,500 Aug 28 04:31 PM TETRAULT LYNN A. Director Aug 26 '24 Option Exercise 18.99 4,300 81,657 7,300 Aug 28 04:31 PM TETRAULT LYNN A. Director Aug 26 '24 Sale 50.01 4,300 215,029 3,000 Aug 28 04:31 PM GOOD JENNIFER L Director Aug 26 '24 Option Exercise 18.63 14,508 270,322 17,508 Aug 28 04:30 PM GOOD JENNIFER L Director Aug 26 '24 Sale 50.01 14,508 725,526 3,000 Aug 28 04:30 PM JENNIFER GOOD Director Aug 26 '24 Proposed Sale 46.12 35,000 1,614,200 Aug 26 04:27 PM LYNN TETRAULT393 COMMONWEALTH Director Aug 26 '24 Proposed Sale 46.12 7,499 345,854 Aug 26 04:27 PM PAMELA CRAMER Officer Aug 26 '24 Proposed Sale 46.12 7,299 336,630 Aug 26 04:26 PM TETRAULT LYNN A. Director Aug 12 '24 Option Exercise 4.15 10,000 41,500 13,000 Aug 14 04:15 PM TETRAULT LYNN A. Director Aug 12 '24 Sale 44.65 10,000 446,462 3,000 Aug 14 04:15 PM Cramer Pamela J. Chief Human Resources Officer Aug 09 '24 Option Exercise 19.02 30,771 585,264 62,506 Aug 13 04:45 PM Cramer Pamela J. Chief Human Resources Officer Aug 09 '24 Sale 45.15 49,006 2,212,498 13,500 Aug 13 04:45 PM LYNN TETRAULT393 COMMONWEALTH Director Aug 12 '24 Proposed Sale 45.26 10,000 452,600 Aug 12 04:13 PM PAMELA CRAMER Officer Aug 09 '24 Proposed Sale 45.87 49,006 2,247,905 Aug 09 04:09 PM Cramer Pamela J. Chief Human Resources Officer Jul 29 '24 Sale 49.06 1,395 68,439 31,735 Jul 30 05:09 PM Shulman Joseph Chief Technical Officer Jul 16 '24 Option Exercise 27.35 10,468 286,300 10,498 Jul 18 05:59 PM Shulman Joseph Chief Technical Officer Jul 16 '24 Sale 53.00 10,468 554,817 30 Jul 18 05:59 PM Shulman Joseph Chief Technical Officer Jul 12 '24 Option Exercise 21.38 5,313 113,592 5,343 Jul 16 04:30 PM Shulman Joseph Chief Technical Officer Jul 12 '24 Sale 50.01 5,313 265,725 30 Jul 16 04:30 PM Shulman Joseph Chief Technical Officer May 09 '24 Option Exercise 6.80 3,984 27,091 4,014 May 13 04:21 PM Shulman Joseph Chief Technical Officer May 09 '24 Sale 38.47 3,984 153,259 30 May 13 04:21 PM German Christopher Paul Corporate Controller & CAO Apr 02 '24 Sale 41.76 368 15,368 795 Apr 03 08:00 PM Shulman Joseph Chief Technical Officer Mar 21 '24 Sale 40.34 18,235 735,600 30 Mar 22 04:55 PM Lee Jennifer Kayden EVP, Head of North America Mar 20 '24 Sale 38.77 18,235 707,005 6,852 Mar 22 04:16 PM Smith Hunter C Chief Financial Officer Mar 19 '24 Sale 39.22 15,515 608,498 97,939 Mar 19 08:57 PM Shulman Joseph Chief Technical Officer Mar 19 '24 Sale 39.22 15,515 608,498 18,265 Mar 19 08:56 PM Meeker David P President and CEO Mar 19 '24 Sale 39.22 45,494 1,784,275 174,605 Mar 19 08:54 PM Mazabraud Yann EVP, Head of International Mar 19 '24 Sale 39.22 16,000 627,520 24,495 Mar 19 08:53 PM Lee Jennifer Kayden EVP, Head of North America Mar 19 '24 Sale 39.22 15,515 608,498 25,087 Mar 19 08:52 PM Cramer Pamela J. Chief Human Resources Officer Mar 19 '24 Sale 39.22 15,515 608,498 30,005 Mar 19 08:50 PM Shulman Joseph Chief Technical Officer Feb 13 '24 Sale 50.00 1,865 93,250 1,119 Feb 15 06:14 PM Shulman Joseph Chief Technical Officer Feb 14 '24 Sale 50.01 1,089 54,461 30 Feb 15 06:14 PM Smith Hunter C Chief Financial Officer Feb 12 '24 Sale 51.38 1,209 62,118 80,413 Feb 13 08:50 PM Smith Hunter C Chief Financial Officer Feb 13 '24 Sale 49.82 709 35,322 79,704 Feb 13 08:50 PM Mazabraud Yann EVP, Head of International Feb 12 '24 Sale 51.38 1,594 81,900 7,702 Feb 13 08:49 PM Mazabraud Yann EVP, Head of International Feb 13 '24 Sale 49.84 957 47,697 6,745 Feb 13 08:49 PM Lee Jennifer Kayden EVP, Head of North America Feb 12 '24 Sale 51.38 1,023 52,562 7,467 Feb 13 08:47 PM Lee Jennifer Kayden EVP, Head of North America Feb 13 '24 Sale 49.83 615 30,645 6,852 Feb 13 08:47 PM Shulman Joseph Chief Technical Officer Feb 09 '24 Option Exercise 21.38 69,190 1,479,282 74,460 Feb 13 08:46 PM Shulman Joseph Chief Technical Officer Feb 09 '24 Sale 50.38 71,774 3,615,982 2,686 Feb 13 08:46 PM Shulman Joseph Chief Technical Officer Feb 12 '24 Sale 51.38 791 40,642 3,457 Feb 13 08:46 PM Shulman Joseph Chief Technical Officer Feb 13 '24 Sale 49.84 473 23,574 2,984 Feb 13 08:46 PM Cramer Pamela J. Chief Human Resources Officer Feb 12 '24 Sale 51.38 696 35,760 11,770 Feb 13 08:45 PM Lee Jennifer Kayden EVP, Head of North America Feb 01 '24 Sale 45.06 1,492 67,230 3,021 Feb 05 06:55 PM Smith Hunter C Chief Financial Officer Feb 01 '24 Sale 45.06 1,616 72,817 75,215 Feb 05 06:54 PM Shulman Joseph Chief Technical Officer Feb 01 '24 Sale 45.06 1,324 59,659 2,614 Feb 05 06:54 PM Meeker David P President and CEO Feb 01 '24 Sale 45.06 4,361 196,507 121,099 Feb 05 06:53 PM Cramer Pamela J. Chief Human Resources Officer Feb 01 '24 Sale 45.06 946 42,627 10,122 Feb 05 06:53 PM Shulman Joseph Chief Technical Officer Dec 28 '23 Option Exercise 21.38 6,800 145,384 7,926 Dec 29 04:30 PM Shulman Joseph Chief Technical Officer Dec 27 '23 Option Exercise 21.38 2,400 51,312 6,141 Dec 29 04:30 PM Shulman Joseph Chief Technical Officer Dec 28 '23 Sale 50.00 7,926 396,318 0 Dec 29 04:30 PM Shulman Joseph Chief Technical Officer Dec 27 '23 Sale 50.01 5,015 250,796 1,126 Dec 29 04:30 PM Smith Hunter C Chief Financial Officer Dec 06 '23 Option Exercise 6.88 20,000 137,600 81,406 Dec 07 04:16 PM Smith Hunter C Chief Financial Officer Dec 05 '23 Option Exercise 6.88 7,026 48,339 68,432 Dec 07 04:16 PM Smith Hunter C Chief Financial Officer Dec 06 '23 Sale 40.00 20,000 800,000 61,406 Dec 07 04:16 PM Smith Hunter C Chief Financial Officer Dec 05 '23 Sale 35.06 7,026 246,360 61,406 Dec 07 04:16 PM Smith Hunter C Chief Financial Officer Nov 24 '23 Option Exercise 6.88 10,974 75,501 72,380 Nov 28 04:05 PM Smith Hunter C Chief Financial Officer Nov 24 '23 Sale 35.02 10,974 384,336 61,406 Nov 28 04:05 PM Shulman Joseph Chief Technical Officer Nov 14 '23 Option Exercise 6.80 27,890 189,652 31,631 Nov 16 04:05 PM Shulman Joseph Chief Technical Officer Nov 14 '23 Sale 32.07 27,890 894,329 3,741 Nov 16 04:05 PM Lee Jennifer Kayden EVP, Head of North America Nov 14 '23 Option Exercise 6.80 12,030 81,804 13,677 Nov 16 04:05 PM Lee Jennifer Kayden EVP, Head of North America Nov 14 '23 Sale 32.01 13,677 437,819 0 Nov 16 04:05 PM Smith Hunter C Chief Financial Officer Nov 14 '23 Option Exercise 6.88 12,000 82,560 73,406 Nov 16 04:05 PM Smith Hunter C Chief Financial Officer Nov 14 '23 Sale 30.38 12,000 364,573 61,406 Nov 16 04:05 PM Lee Jennifer Kayden EVP, Head of North America Nov 08 '23 Option Exercise 6.80 5,712 38,842 7,359 Nov 13 05:44 PM Lee Jennifer Kayden EVP, Head of North America Nov 09 '23 Option Exercise 6.80 3,438 23,378 5,085 Nov 13 05:44 PM Lee Jennifer Kayden EVP, Head of North America Nov 08 '23 Sale 28.90 5,712 165,104 1,647 Nov 13 05:44 PM Lee Jennifer Kayden EVP, Head of North America Nov 09 '23 Sale 27.69 3,438 95,183 1,647 Nov 13 05:44 PM Lee Jennifer Kayden EVP, Head of North America Nov 03 '23 Option Exercise 6.80 80 544 1,727 Nov 07 06:17 PM Lee Jennifer Kayden EVP, Head of North America Nov 03 '23 Sale 28.00 80 2,240 1,647 Nov 07 06:17 PM
Index RUT P/E - EPS (ttm) -0.62 Insider Own 1.31% Shs Outstand 127.37M Perf Week -0.85%
Market Cap 2.08B Forward P/E 83.69 EPS next Y 0.19 Insider Trans -0.12% Shs Float 126.47M Perf Month -1.03%
Income -78.55M PEG - EPS next Q 0.01 Inst Own 98.60% Short Float 4.06% Perf Quarter 23.46%
Sales 628.25M P/S 3.32 EPS this Y 151.19% Inst Trans -4.35% Short Ratio 7.08 Perf Half Y 5.31%
Book/sh 7.16 P/B 2.27 EPS next Y 216.28% ROA -4.71% Short Interest 5.14M Perf Year 30.29%
Cash/sh 3.03 P/C 5.37 EPS next 5Y - ROE -8.39% 52W Range 11.03 - 21.22 Perf YTD 0.49%
Dividend Est. - P/FCF - EPS past 5Y - ROI -5.96% 52W High -23.37% Beta 1.19
Dividend TTM - Quick Ratio 1.93 Sales past 5Y 17.35% Gross Margin 39.51% 52W Low 47.42% ATR (14) 0.60
Dividend Ex-Date - Current Ratio 2.01 EPS Y/Y TTM 32.16% Oper. Margin -14.01% RSI (14) 51.76 Volatility 2.98% 3.38%
Employees 2100 Debt/Eq 0.66 Sales Y/Y TTM 13.89% Profit Margin -12.50% Recom 1.57 Target Price 20.75
Option/Short Yes / Yes LT Debt/Eq 0.44 EPS Q/Q 24.01% Payout - Rel Volume 0.78 Prev Close 16.48
Sales Surprise 1.66% EPS Surprise 1067.74% Sales Q/Q 11.97% Earnings Jul 29 AMC Avg Volume 725.55K Price 16.26
SMA20 0.48% SMA50 1.74% SMA200 5.22% Trades
Volume 499,376 Change -1.33%
Date
Action
Analyst
Rating Change
Price Target Change
May-01-24 Resumed Craig Hallum
Buy
$26
Dec-29-23 Reiterated BTIG Research
Buy
$25 → $21
Aug-21-23 Upgrade Stephens
Equal-Weight → Overweight
$18
May-16-23 Downgrade Raymond James
Outperform → Mkt Perform
May-09-23 Upgrade BTIG Research
Neutral → Buy
$25
Feb-24-23 Upgrade The Benchmark Company
Hold → Buy
$20
Feb-01-23 Upgrade Needham
Hold → Buy
$15
Aug-26-22 Downgrade The Benchmark Company
Buy → Hold
Aug-22-22 Downgrade Needham
Buy → Hold
Jun-03-22 Initiated Piper Sandler
Overweight
$13
Mar-29-22 Downgrade Stephens
Overweight → Equal-Weight
$34 → $16
Mar-29-22 Downgrade BofA Securities
Buy → Neutral
$25 → $18
Jan-18-22 Resumed Stephens
Overweight
$40
Dec-16-21 Initiated Cowen
Outperform
$42
Nov-05-21 Downgrade Morgan Stanley
Overweight → Equal-Weight
Oct-14-21 Upgrade Raymond James
Mkt Perform → Outperform
$53
Jun-03-21 Initiated Goldman
Buy
$55
Feb-25-21 Resumed Needham
Buy
$65
Feb-25-21 Downgrade Raymond James
Outperform → Mkt Perform
Jan-28-21 Initiated Truist
Buy
$65
Show Previous Ratings
Sep-11-24 08:05AM
Aug-29-24 08:05AM
Jul-29-24 06:00PM
04:33PM
(Associated Press Finance)
04:05PM
08:09AM
Loading…
Jul-20-24 08:09AM
Jul-09-24 07:00AM
Jun-13-24 08:00AM
Jun-10-24 01:00AM
May-28-24 08:05AM
May-02-24 02:14PM
May-01-24 03:04AM
Apr-30-24 11:53AM
11:25AM
10:30AM
08:52AM
Loading…
08:52AM
08:40AM
07:37AM
(Associated Press Finance)
07:30AM
Apr-23-24 10:00AM
Apr-18-24 07:05AM
Apr-09-24 07:00AM
Mar-27-24 08:30AM
Mar-20-24 12:00PM
09:55AM
07:00AM
Mar-01-24 07:05AM
Feb-29-24 08:12AM
Feb-28-24 09:55AM
Feb-21-24 09:57AM
06:38AM
Loading…
06:38AM
(Thomson Reuters StreetEvents)
Feb-20-24 07:00PM
05:35PM
04:39PM
04:37PM
(Associated Press Finance)
04:05PM
Feb-01-24 07:05AM
Jan-30-24 09:15AM
07:05AM
Jan-12-24 05:20AM
Jan-02-24 07:05AM
Dec-28-23 04:30PM
(Investor's Business Daily) -18.10%
03:08PM
(Investor's Business Daily)
12:07PM
(Associated Press Finance)
08:10AM
Dec-05-23 08:00AM
Nov-14-23 07:00AM
Nov-13-23 09:55AM
Nov-07-23 09:01AM
Nov-06-23 09:00PM
06:10PM
(Associated Press Finance)
04:33PM
04:05PM
Nov-01-23 10:01AM
Oct-30-23 03:46PM
10:00AM
Oct-27-23 09:55AM
Oct-24-23 07:00AM
05:20AM
02:18AM
Oct-18-23 08:26AM
Oct-17-23 09:20AM
09:15AM
Oct-13-23 12:00PM
Aug-08-23 11:30AM
09:22AM
(Associated Press Finance)
07:00AM
Jul-27-23 07:00AM
Jul-18-23 07:10AM
Jun-29-23 07:00AM
Jun-21-23 08:00PM
Jun-15-23 04:45PM
Jun-08-23 01:36PM
Jun-06-23 08:02AM
Jun-05-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-17-23 08:16AM
May-16-23 06:59AM
May-10-23 01:26AM
May-09-23 01:39PM
May-08-23 06:15PM
05:02PM
04:05PM
May-03-23 07:00AM
May-01-23 06:29AM
Apr-26-23 08:00PM
Apr-17-23 07:00AM
Apr-14-23 06:51AM
Apr-11-23 07:00AM
Apr-06-23 07:00AM
Mar-27-23 07:00AM
Mar-22-23 08:00AM
Mar-21-23 08:06AM
Mar-19-23 06:24AM
Mar-16-23 07:00AM
Mar-13-23 07:00AM
Feb-28-23 07:00AM
Feb-23-23 03:34PM
03:32PM
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Olivo Alicia C General Counsel Aug 15 '24 Sale 16.05 1,040 16,695 43,813 Aug 19 04:17 PM ALICIA OLIVO Officer Aug 15 '24 Proposed Sale 15.82 1,040 16,453 Aug 15 04:29 PM BRUCE K CROWTHER Officer Aug 15 '24 Proposed Sale 15.95 8,353 133,243 Aug 15 04:12 PM Zook Anthony P. Director Aug 10 '24 Option Exercise 0.00 11,336 0 11,336 Aug 13 04:40 PM TETRAULT LYNN A. Director Aug 10 '24 Option Exercise 0.00 11,336 0 61,398 Aug 13 04:37 PM Perez David Brian Director Aug 10 '24 Option Exercise 0.00 11,336 0 21,636 Aug 13 04:34 PM Kelly Michael Aaron Director Aug 10 '24 Option Exercise 0.00 11,336 0 31,755 Aug 13 04:32 PM KANOVSKY STEPHEN M Director Aug 10 '24 Option Exercise 0.00 11,336 0 36,090 Aug 13 04:27 PM HANNAH ALISON L. Director Aug 10 '24 Option Exercise 0.00 11,336 0 118,769 Aug 13 04:24 PM Gunn Neil Director Aug 10 '24 Option Exercise 0.00 11,336 0 11,336 Aug 13 04:21 PM Floegel Elizabeth Director Aug 10 '24 Option Exercise 0.00 11,336 0 11,336 Aug 13 04:17 PM Olivo Alicia C General Counsel May 15 '24 Sale 15.74 1,049 16,511 44,867 May 17 04:07 PM Smith Christopher M Chief Executive Officer May 11 '24 Option Exercise 0.00 96,126 0 679,432 May 14 09:39 PM Olivo Alicia C General Counsel May 11 '24 Option Exercise 0.00 13,004 0 45,916 May 14 09:39 PM Stone Warren Chief Commerical Officer May 11 '24 Option Exercise 0.00 19,224 0 100,658 May 14 09:38 PM Sherman Jeffrey Scott Chief Financial Officer May 11 '24 Option Exercise 0.00 26,010 0 148,505 May 14 09:38 PM Harris Melody Chf Ops Off, Pres, Informatics May 11 '24 Option Exercise 0.00 7,068 0 110,023 May 14 09:38 PM TETRAULT LYNN A. Director Mar 04 '24 Sale 15.97 6,112 97,579 50,062 Mar 06 04:26 PM Olivo Alicia C General Counsel Feb 15 '24 Sale 14.96 2,587 38,713 34,866 Feb 20 04:32 PM Olivo Alicia C General Counsel Nov 17 '23 Sale 18.39 2,669 49,083 37,140 Nov 20 04:33 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
